| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Palliative Care | 28 | 2025 | 446 | 2.740 |
Why?
|
| Neoplasms | 39 | 2025 | 2965 | 2.180 |
Why?
|
| Survivors | 16 | 2016 | 352 | 2.030 |
Why?
|
| Terminal Care | 10 | 2021 | 114 | 1.390 |
Why?
|
| Patient Navigation | 7 | 2018 | 26 | 1.300 |
Why?
|
| Quality of Life | 19 | 2023 | 2116 | 1.250 |
Why?
|
| Telemedicine | 5 | 2022 | 524 | 1.080 |
Why?
|
| Self Care | 3 | 2017 | 231 | 0.940 |
Why?
|
| Caregivers | 10 | 2020 | 585 | 0.910 |
Why?
|
| Medicare | 8 | 2019 | 440 | 0.760 |
Why?
|
| Advance Care Planning | 4 | 2018 | 41 | 0.750 |
Why?
|
| Breast Neoplasms | 5 | 2024 | 2653 | 0.730 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2022 | 85 | 0.700 |
Why?
|
| Aged | 46 | 2025 | 21279 | 0.650 |
Why?
|
| Patient Education as Topic | 5 | 2019 | 466 | 0.620 |
Why?
|
| Patient Acceptance of Health Care | 5 | 2019 | 505 | 0.590 |
Why?
|
| Fatigue | 3 | 2017 | 199 | 0.590 |
Why?
|
| Stress, Psychological | 8 | 2017 | 564 | 0.560 |
Why?
|
| Decision Making | 3 | 2018 | 687 | 0.540 |
Why?
|
| Aged, 80 and over | 27 | 2025 | 6922 | 0.540 |
Why?
|
| Hospice Care | 5 | 2019 | 30 | 0.520 |
Why?
|
| Cancer Pain | 1 | 2017 | 25 | 0.510 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2014 | 1357 | 0.490 |
Why?
|
| Continuity of Patient Care | 2 | 2018 | 143 | 0.470 |
Why?
|
| Patient Care Planning | 2 | 2016 | 123 | 0.470 |
Why?
|
| Emergency Medical Services | 2 | 2017 | 423 | 0.460 |
Why?
|
| Self-Management | 1 | 2017 | 117 | 0.450 |
Why?
|
| Transitional Care | 1 | 2015 | 17 | 0.450 |
Why?
|
| Restraint, Physical | 1 | 2015 | 31 | 0.440 |
Why?
|
| Cognitive Dysfunction | 2 | 2023 | 355 | 0.440 |
Why?
|
| Female | 55 | 2025 | 71316 | 0.430 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 2 | 2006 | 101 | 0.420 |
Why?
|
| Humans | 84 | 2025 | 131967 | 0.420 |
Why?
|
| Chronic Disease | 2 | 2017 | 1239 | 0.410 |
Why?
|
| Health Status | 2 | 2017 | 388 | 0.410 |
Why?
|
| Survival Rate | 10 | 2018 | 2154 | 0.410 |
Why?
|
| Cognition Disorders | 3 | 2015 | 565 | 0.390 |
Why?
|
| Middle Aged | 31 | 2025 | 28911 | 0.390 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2014 | 137 | 0.380 |
Why?
|
| Volunteers | 4 | 2015 | 24 | 0.370 |
Why?
|
| Male | 48 | 2025 | 65357 | 0.370 |
Why?
|
| Self Report | 1 | 2015 | 563 | 0.350 |
Why?
|
| Disease Management | 2 | 2016 | 565 | 0.340 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2010 | 66 | 0.320 |
Why?
|
| Heart Failure | 6 | 2020 | 2315 | 0.310 |
Why?
|
| Hospice and Palliative Care Nursing | 2 | 2020 | 17 | 0.310 |
Why?
|
| Feasibility Studies | 5 | 2025 | 838 | 0.290 |
Why?
|
| Social Support | 4 | 2018 | 375 | 0.290 |
Why?
|
| Communication | 4 | 2018 | 532 | 0.290 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2018 | 910 | 0.290 |
Why?
|
| Veterans | 3 | 2015 | 1801 | 0.290 |
Why?
|
| Adaptation, Psychological | 5 | 2018 | 437 | 0.290 |
Why?
|
| Medical Oncology | 5 | 2017 | 238 | 0.280 |
Why?
|
| Brain Neoplasms | 3 | 2018 | 1300 | 0.280 |
Why?
|
| Health Expenditures | 3 | 2018 | 134 | 0.270 |
Why?
|
| Gastroscopy | 1 | 2007 | 98 | 0.260 |
Why?
|
| Adult | 20 | 2025 | 31734 | 0.260 |
Why?
|
| Extracorporeal Membrane Oxygenation | 2 | 2024 | 675 | 0.260 |
Why?
|
| Liability, Legal | 1 | 2007 | 49 | 0.260 |
Why?
|
| Gastrostomy | 1 | 2007 | 88 | 0.260 |
Why?
|
| United States | 16 | 2023 | 11827 | 0.250 |
Why?
|
| Patient Participation | 3 | 2017 | 245 | 0.230 |
Why?
|
| Family | 2 | 2020 | 593 | 0.230 |
Why?
|
| Alabama | 7 | 2019 | 44 | 0.230 |
Why?
|
| Professional-Patient Relations | 2 | 2018 | 93 | 0.230 |
Why?
|
| Glioblastoma | 1 | 2009 | 347 | 0.230 |
Why?
|
| Cancer Survivors | 2 | 2019 | 267 | 0.230 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2025 | 221 | 0.230 |
Why?
|
| Enteral Nutrition | 1 | 2007 | 281 | 0.220 |
Why?
|
| Health Promotion | 3 | 2024 | 408 | 0.220 |
Why?
|
| Ethics, Medical | 1 | 2007 | 399 | 0.220 |
Why?
|
| Patient Care Team | 2 | 2022 | 558 | 0.220 |
Why?
|
| Social Work | 2 | 2015 | 21 | 0.210 |
Why?
|
| Uncompensated Care | 1 | 2004 | 12 | 0.210 |
Why?
|
| Mobile Health Units | 1 | 2024 | 29 | 0.210 |
Why?
|
| Neoplasm Staging | 3 | 2017 | 1325 | 0.210 |
Why?
|
| Health Personnel | 3 | 2019 | 550 | 0.210 |
Why?
|
| Medically Uninsured | 1 | 2024 | 77 | 0.210 |
Why?
|
| Hospices | 2 | 2019 | 8 | 0.200 |
Why?
|
| Mammography | 1 | 2024 | 131 | 0.200 |
Why?
|
| Hospitalization | 5 | 2018 | 1942 | 0.200 |
Why?
|
| Hospitals, Veterans | 2 | 2016 | 346 | 0.200 |
Why?
|
| Surveys and Questionnaires | 7 | 2025 | 4058 | 0.200 |
Why?
|
| Depression | 4 | 2017 | 1352 | 0.200 |
Why?
|
| Emergency Treatment | 2 | 2014 | 85 | 0.190 |
Why?
|
| Qualitative Research | 3 | 2017 | 709 | 0.190 |
Why?
|
| Exercise | 4 | 2019 | 866 | 0.190 |
Why?
|
| Anxiety | 3 | 2023 | 1030 | 0.180 |
Why?
|
| Critical Care | 2 | 2024 | 681 | 0.170 |
Why?
|
| Patient Selection | 3 | 2017 | 726 | 0.170 |
Why?
|
| Pilot Projects | 4 | 2025 | 1457 | 0.170 |
Why?
|
| Biological Products | 1 | 2023 | 143 | 0.170 |
Why?
|
| Patient Satisfaction | 2 | 2022 | 460 | 0.170 |
Why?
|
| Comorbidity | 5 | 2017 | 1607 | 0.170 |
Why?
|
| Attitude of Health Personnel | 2 | 2024 | 721 | 0.160 |
Why?
|
| Prospective Studies | 4 | 2017 | 6522 | 0.160 |
Why?
|
| Interdisciplinary Studies | 1 | 2020 | 5 | 0.160 |
Why?
|
| Southeastern United States | 2 | 2019 | 35 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2022 | 5122 | 0.160 |
Why?
|
| Interviews as Topic | 3 | 2017 | 442 | 0.150 |
Why?
|
| Follow-Up Studies | 6 | 2023 | 5298 | 0.150 |
Why?
|
| Health Services Needs and Demand | 2 | 2018 | 169 | 0.150 |
Why?
|
| Healthy Lifestyle | 1 | 2019 | 33 | 0.150 |
Why?
|
| Rural Health Services | 1 | 2019 | 33 | 0.140 |
Why?
|
| Patient Care | 2 | 2016 | 99 | 0.140 |
Why?
|
| Self Efficacy | 2 | 2017 | 205 | 0.140 |
Why?
|
| Pain | 3 | 2021 | 439 | 0.140 |
Why?
|
| Health Care Costs | 2 | 2018 | 400 | 0.140 |
Why?
|
| Patients | 1 | 2018 | 122 | 0.130 |
Why?
|
| Age Factors | 5 | 2018 | 2869 | 0.130 |
Why?
|
| Survivorship | 1 | 2017 | 46 | 0.130 |
Why?
|
| Academic Medical Centers | 1 | 2019 | 322 | 0.130 |
Why?
|
| Menopause | 1 | 2017 | 87 | 0.130 |
Why?
|
| Focus Groups | 2 | 2015 | 229 | 0.130 |
Why?
|
| Prescription Drugs | 1 | 2017 | 52 | 0.130 |
Why?
|
| Symptom Assessment | 1 | 2017 | 111 | 0.130 |
Why?
|
| Pandemics | 1 | 2024 | 1165 | 0.130 |
Why?
|
| Home Care Services | 2 | 2014 | 69 | 0.120 |
Why?
|
| Insurance, Health | 1 | 2017 | 140 | 0.120 |
Why?
|
| Pharmaceutical Preparations | 1 | 2017 | 81 | 0.120 |
Why?
|
| Regression Analysis | 3 | 2017 | 773 | 0.120 |
Why?
|
| Health Behavior | 2 | 2019 | 390 | 0.120 |
Why?
|
| Counseling | 1 | 2018 | 237 | 0.120 |
Why?
|
| Health Resources | 1 | 2017 | 128 | 0.120 |
Why?
|
| Treatment Outcome | 9 | 2020 | 13011 | 0.120 |
Why?
|
| Emergency Service, Hospital | 3 | 2018 | 1215 | 0.120 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 3843 | 0.110 |
Why?
|
| Tertiary Prevention | 1 | 2015 | 2 | 0.110 |
Why?
|
| Nursing Research | 1 | 2015 | 17 | 0.110 |
Why?
|
| Aftercare | 1 | 2016 | 154 | 0.110 |
Why?
|
| Prognosis | 4 | 2018 | 4961 | 0.110 |
Why?
|
| Life Style | 2 | 2015 | 445 | 0.110 |
Why?
|
| Community-Based Participatory Research | 1 | 2015 | 63 | 0.110 |
Why?
|
| Sleep Wake Disorders | 2 | 2014 | 204 | 0.110 |
Why?
|
| Helping Behavior | 1 | 2014 | 5 | 0.110 |
Why?
|
| Retrospective Studies | 9 | 2019 | 17703 | 0.110 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 1519 | 0.100 |
Why?
|
| Patient Compliance | 1 | 2017 | 469 | 0.100 |
Why?
|
| Psychotherapy, Group | 1 | 2014 | 58 | 0.100 |
Why?
|
| Ambulatory Care | 2 | 2013 | 407 | 0.100 |
Why?
|
| Medical Staff, Hospital | 1 | 2014 | 94 | 0.100 |
Why?
|
| Occupational Diseases | 1 | 2014 | 79 | 0.100 |
Why?
|
| Bone Neoplasms | 1 | 2018 | 452 | 0.100 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2014 | 85 | 0.100 |
Why?
|
| Immunization | 1 | 2014 | 307 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 3 | 2015 | 1307 | 0.100 |
Why?
|
| Communicable Diseases | 1 | 2014 | 158 | 0.090 |
Why?
|
| Pain Management | 1 | 2014 | 203 | 0.090 |
Why?
|
| Outpatients | 1 | 2014 | 266 | 0.090 |
Why?
|
| Delivery of Health Care | 2 | 2017 | 683 | 0.090 |
Why?
|
| Memory | 1 | 2015 | 360 | 0.090 |
Why?
|
| Chronic Pain | 1 | 2014 | 164 | 0.090 |
Why?
|
| Socioeconomic Factors | 1 | 2015 | 895 | 0.090 |
Why?
|
| Erectile Dysfunction | 1 | 2014 | 196 | 0.090 |
Why?
|
| Diet | 2 | 2015 | 1118 | 0.090 |
Why?
|
| Motor Activity | 1 | 2014 | 507 | 0.090 |
Why?
|
| Referral and Consultation | 3 | 2024 | 564 | 0.080 |
Why?
|
| Inpatients | 3 | 2021 | 544 | 0.080 |
Why?
|
| Mental Health Services | 1 | 2013 | 272 | 0.080 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 432 | 0.080 |
Why?
|
| Hospital Mortality | 1 | 2015 | 1076 | 0.080 |
Why?
|
| Activities of Daily Living | 2 | 2009 | 409 | 0.080 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2013 | 327 | 0.070 |
Why?
|
| Cognition | 1 | 2015 | 845 | 0.070 |
Why?
|
| Vaccination | 1 | 2014 | 1043 | 0.070 |
Why?
|
| Colorectal Neoplasms | 1 | 2015 | 639 | 0.070 |
Why?
|
| Models, Statistical | 1 | 2011 | 493 | 0.070 |
Why?
|
| Risk Factors | 2 | 2015 | 10998 | 0.070 |
Why?
|
| Affect | 2 | 2020 | 170 | 0.070 |
Why?
|
| Executive Function | 1 | 2009 | 136 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 744 | 0.070 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2009 | 393 | 0.070 |
Why?
|
| Residence Characteristics | 1 | 2010 | 293 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1281 | 0.070 |
Why?
|
| Tracheotomy | 1 | 2007 | 33 | 0.070 |
Why?
|
| Young Adult | 4 | 2019 | 10108 | 0.060 |
Why?
|
| Pain Measurement | 2 | 2020 | 356 | 0.060 |
Why?
|
| Early Detection of Cancer | 2 | 2024 | 418 | 0.060 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2009 | 846 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2009 | 998 | 0.060 |
Why?
|
| Psychometrics | 1 | 2009 | 678 | 0.060 |
Why?
|
| Texas | 2 | 2024 | 3629 | 0.060 |
Why?
|
| Informed Consent | 1 | 2007 | 343 | 0.050 |
Why?
|
| Persuasive Communication | 1 | 2024 | 11 | 0.050 |
Why?
|
| Medical Audit | 2 | 2016 | 96 | 0.050 |
Why?
|
| Guidelines as Topic | 2 | 2014 | 200 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2013 | 1545 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2023 | 188 | 0.050 |
Why?
|
| Cardiovascular Diseases | 1 | 2015 | 2088 | 0.050 |
Why?
|
| Program Evaluation | 1 | 2004 | 443 | 0.050 |
Why?
|
| Patient Comfort | 1 | 2021 | 5 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2009 | 3095 | 0.040 |
Why?
|
| Advance Directives | 1 | 2021 | 32 | 0.040 |
Why?
|
| Single-Blind Method | 1 | 2020 | 241 | 0.040 |
Why?
|
| Cancer Care Facilities | 1 | 2019 | 33 | 0.040 |
Why?
|
| Health Services for the Aged | 1 | 2018 | 34 | 0.040 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2018 | 37 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2015 | 1255 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 701 | 0.030 |
Why?
|
| New Hampshire | 1 | 2017 | 7 | 0.030 |
Why?
|
| Smoking Cessation | 1 | 2019 | 190 | 0.030 |
Why?
|
| Multicenter Studies as Topic | 1 | 2018 | 300 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2018 | 173 | 0.030 |
Why?
|
| Forecasting | 1 | 2019 | 361 | 0.030 |
Why?
|
| Drug Costs | 1 | 2017 | 62 | 0.030 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2017 | 33 | 0.030 |
Why?
|
| Costs and Cost Analysis | 1 | 2017 | 155 | 0.030 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2018 | 144 | 0.030 |
Why?
|
| Learning | 1 | 2020 | 374 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2018 | 291 | 0.030 |
Why?
|
| Urban Health | 1 | 2016 | 85 | 0.030 |
Why?
|
| Perception | 1 | 2017 | 227 | 0.030 |
Why?
|
| Weight Loss | 1 | 2019 | 530 | 0.030 |
Why?
|
| Geriatrics | 1 | 2016 | 75 | 0.030 |
Why?
|
| Risk Assessment | 2 | 2015 | 3708 | 0.030 |
Why?
|
| Patient Acuity | 1 | 2015 | 67 | 0.030 |
Why?
|
| Patient Preference | 1 | 2017 | 146 | 0.030 |
Why?
|
| Life Expectancy | 1 | 2015 | 63 | 0.030 |
Why?
|
| Withholding Treatment | 1 | 2015 | 76 | 0.030 |
Why?
|
| Wakefulness-Promoting Agents | 1 | 2014 | 1 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 1261 | 0.030 |
Why?
|
| Employment | 1 | 2015 | 71 | 0.030 |
Why?
|
| Behavior | 1 | 2014 | 70 | 0.030 |
Why?
|
| Quality of Health Care | 1 | 2017 | 411 | 0.030 |
Why?
|
| Methylphenidate | 1 | 2014 | 57 | 0.030 |
Why?
|
| Occupational Therapy | 1 | 2014 | 37 | 0.030 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 132 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 1236 | 0.030 |
Why?
|
| Weight Reduction Programs | 1 | 2014 | 58 | 0.030 |
Why?
|
| Benzhydryl Compounds | 1 | 2014 | 75 | 0.030 |
Why?
|
| Psychology | 1 | 2013 | 56 | 0.030 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 129 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 1400 | 0.020 |
Why?
|
| Clinical Decision-Making | 1 | 2016 | 313 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2016 | 544 | 0.020 |
Why?
|
| Physician's Role | 1 | 2015 | 165 | 0.020 |
Why?
|
| Rural Population | 1 | 2015 | 260 | 0.020 |
Why?
|
| Education, Medical | 1 | 2017 | 287 | 0.020 |
Why?
|
| Carboplatin | 1 | 2013 | 80 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2013 | 110 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2013 | 82 | 0.020 |
Why?
|
| Motivation | 1 | 2015 | 332 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 228 | 0.020 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2016 | 713 | 0.020 |
Why?
|
| Research Design | 1 | 2016 | 723 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2013 | 262 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2013 | 741 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2018 | 3453 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3928 | 0.020 |
Why?
|
| Sex Factors | 1 | 2015 | 1352 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2015 | 401 | 0.020 |
Why?
|
| Body Weight | 1 | 2015 | 990 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2011 | 227 | 0.020 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 459 | 0.020 |
Why?
|
| Adolescent | 2 | 2019 | 21008 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2015 | 791 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 6285 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 1141 | 0.020 |
Why?
|
| Prevalence | 1 | 2015 | 2697 | 0.020 |
Why?
|
| Nursing Assessment | 1 | 2007 | 21 | 0.020 |
Why?
|
| Ventilator Weaning | 1 | 2007 | 30 | 0.020 |
Why?
|
| Nurse's Role | 1 | 2007 | 38 | 0.020 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 650 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1812 | 0.020 |
Why?
|
| Safety | 1 | 2007 | 216 | 0.020 |
Why?
|
| Dyspnea | 1 | 2007 | 161 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2019 | 8604 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2007 | 371 | 0.010 |
Why?
|
| Infant | 1 | 2019 | 13332 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 15066 | 0.010 |
Why?
|
| Child | 1 | 2019 | 26332 | 0.010 |
Why?
|